SNYK Pharmaceutical

SNYK Pharmaceutical, officially known as Beijing Shennong Yikang Pharmaceutical Technology, is a biopharmaceutical company based in Beijing, China, that focuses on the development of innovative treatments derived from traditional botanical sources. The company's lead clinical program, TQS (also known as Bitter Clove Venting Plug), is a botanical extract therapy currently in Phase III clinical trials for the treatment of postoperative ileus. TQS is formulated from Muskmelon-Base and Arecae semen extracts and is designed to stimulate gastrointestinal motility to accelerate recovery following abdominal surgery. Founded in 2012, SNYK Pharmaceutical utilizes modern clinical research standards to validate and commercialize natural product-based therapies for unmet needs in gastrointestinal health. The company maintains research collaborations with major medical institutions, including Beijing University People's Hospital.